The impact of ursodeoxycholic acid on gallstone disease after bariatric surgery: a meta-analysis of randomized control trials
-
Published:2022-01
Issue:1
Volume:18
Page:77-84
-
ISSN:1550-7289
-
Container-title:Surgery for Obesity and Related Diseases
-
language:en
-
Short-container-title:Surgery for Obesity and Related Diseases
Author:
Fearon Naomi M.ORCID,
Kearns Emma C.ORCID,
Kennedy Czara A.,
Conneely John B.,
Heneghan Helen M.
Reference43 articles.
1. Global burden of obesity in 2005 and projections to 2030;Kelly;Int J Obesity,2008
2. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial;Mingrone;Lancet,2015
3. Changes in non-diabetic comorbid disease status following laparoscopic vertical sleeve gastrectomy (LVSG) versus laparoscopic Roux-en-Y gastric bypass (LRYGB) procedures: a systematic review of randomized controlled trials;Osland;Obes Surg,2017
4. Bariatric surgery versus intensive medical therapy for diabetes—5-Year Outcomes;Schauer;N Eng J Med,2017
5. Yuan S, Gill D, Giovannucci EL, Larsson SC. Obesity, type 2 diabetes, lifestyle factors and risk of gallstone disease: a Mendelian randomization investigation. Clin Gastroenterol Heptal. 2021 Jan 6:S1542-3565(21)00001-X. https://doi.org/10.1016/j.cgh.2020.12.034. Epub ahead of print. PMID: 33418132.
Cited by
12 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献